Risk Factors for Discontinuation of Treatment for Neovascular Age-Related Macular Degeneration.

Published in: Ophthalmic epidemiology (2017)

Almost half of the patients starting anti-VEGF therapy discontinue treatment during the first year. Patients with risk factors may require additional support to continue with the treatment. Aflibercept therapy could be an alternative to patients at risk of treatment discontinuation.

Keyphrases

age related macular degeneration
risk factors
end stage renal disease
chronic kidney disease
newly diagnosed
vascular endothelial growth factor
endothelial cells
peritoneal dialysis
prognostic factors
smoking cessation